A
Arleen D. Auerbach
Researcher at Rockefeller University
Publications - 134
Citations - 11167
Arleen D. Auerbach is an academic researcher from Rockefeller University. The author has contributed to research in topics: Fanconi anemia & FANCA. The author has an hindex of 50, co-authored 131 publications receiving 10551 citations. Previous affiliations of Arleen D. Auerbach include Icahn School of Medicine at Mount Sinai & Medical College of Wisconsin.
Papers
More filters
Journal ArticleDOI
The clinical phenotype of children with Fanconi anemia caused by biallelic FANCD1/BRCA2 mutations
Kasiani C. Myers,Stella M. Davies,Richard E. Harris,Sheri L. Spunt,Teresa A. Smolarek,Sarah L. Zimmerman,Richard McMasters,Lars M. Wagner,Robin Mueller,Arleen D. Auerbach,Parinda A. Mehta +10 more
TL;DR: Clinical and molecular features of three patients with FA associated with FANCD1/BRCA2 mutations are reported, including two novel mutations, and treatment of malignancy and associated side effects in this particularly vulnerable group are discussed.
Planning the human variome project: the Spain report
Jim Kaput,Richard G.H. Cotton,Lauren Hardman,Maggie Watson,AI Al Aqeel,Jumana Y. Al-Aama,Fahd Al-Mulla,Santos Alonso,Stefan Aretz,Arleen D. Auerbach,Bharati Bapat,Inge Bernstein,Jong Bhak,Stacey L. Bleoo,H Blocker,Steven E. Brenner,John Burn,Mariona Bustamante,Rita Calzone,Anne Cambon-Thomsen,M Cargill,Paola Carrera,Lawrence Cavedon,Yoon Shin Cho,YJ Chung,Mireille Claustres,Garry R. Cutting,Raymond Dalgleish,J.T. den Dunnen,C Diaz,Steven F. Dobrowolski,dos Santos,Rosemary Ekong,SB Flanagan,Paul Flicek,Yoichi Furukawa,Maurizio Genuardi,Ho Ghang,M. V. Golubenko,Greenblatt,Ada Hamosh,John M. Hancock,Ross C. Hardison,Terence M. Harrison,Robert Hoffmann,R Horaitis,Heather J. Howard,Carol Isaacson Barash,Neskuts Izagirre,Jongsun Jung,T Kojima,Sandrine Laradi,YS Lee,Jy Lee,Vera Lúcia Gil-da-Silva-Lopes,Finlay A. Macrae,Donna Maglott,Makia J. Marafie,Sharon Marsh,Yoichi Matsubara,Ludwine Messiaen,G Moslein,Mihai G. Netea,ML Norton,Peter J. Oefner,William S. Oetting,James O'Leary,AM de Ramirez,Mark H. Paalman,Jillian S. Parboosingh,George P. Patrinos,Giuditta Perozzi,Ian Phillips,Susan Povey,Suyash Prasad,Ming Qi,DJ Quin,Rajkumar Ramesar,Carolyn Sue Richards,Judy Savige,D. Scheible,Rodney J. Scott,Daniela Seminara,Elizabeth A. Shephard,Rolf H. Sijmons,Timothy D. Smith,María-Jesús Sobrido,Toshihiro Tanaka,Sean V. Tavtigian,Graham R. Taylor,Jon W. Teague,Thoralf Töpel,Mollie Ullman-Cullere,Joji Utsunomiya,HJ van Kranen,Mauno Vihinen,Emily L. Webb,Thomas K. Weber,Meredith Yeager,Young Ii Yeom +99 more
TL;DR: The Human Variome Project was proposed initially to systematically collect mutations that cause human disease and create a cyber infrastructure to link locus specific databases (LSDB) and the discussions and recommendations from the 2008 HVP planning meeting held in San Feliu de Guixols, Spain, in May 2008 are reported.
Journal ArticleDOI
Postoperative clinical radiosensitivity in patients with fanconi anemia and head and neck squamous cell carcinoma.
Andrew C. Birkeland,Arleen D. Auerbach,Erica Sanborn,Erica Sanborn,Bhupesh Parashar,William I. Kuhel,Settara C. Chandrasekharappa,Agata Smogorzewska,David I. Kutler +8 more
TL;DR: Patients with FA have a high rate of complications from radiotherapy and common adverse effects, particularly mucositis, are especially prevalent and difficult to manage in this population.
Journal ArticleDOI
The PISSLRE Gene: Structure, Exon Skipping, and Exclusion as Tumor Suppressor in Breast Cancer
Joanna Crawford,Leonarda Ianzano,Maria Savino,S.A. Whitmore,Anne-Marie Cleton-Jansen,Chatri Settasatian,Maria D'Apolito,Ram Seshadri,Jan C. Pronk,Arleen D. Auerbach,Peter C. Verlander,Christopher G. Mathew,Alex J. Tipping,Norman A. Doggett,Leopoldo Zelante,David F. Callen,Anna Savoia +16 more
TL;DR: It is concluded that another tumor suppressor must be targeted by LOH in sporadic breast cancer, and the PISSLRE gene is screened by analyzing each exon by single-strand conformational polymorphism.
Journal ArticleDOI
Acute myeloid leukemia as the first hematologic manifestation of Fanconi anemia.
Arleen D. Auerbach,Arleen D. Auerbach,[edited by] Michael A. Weiner,Dorothy Warburton,Kwame Yeboa,Li Lu,Hal E. Broxmeyer +6 more
TL;DR: A six‐year-old girl with Fanconi anemia who developed acute myeloid leukemia (AML) as the first hematologic manifestation of the syndrome remains in remission 18 mo after diagnosis although her management is complicated by unusual sensitivity to chemotherapeutic agents.